Allergan Plc
(NYSE : AGN)

( )
AGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.17%138.371.9%$228.28m
MYLMylan NV -2.60%16.113.2%$109.33m
TEVATeva Pharmaceutical Industries Ltd. -2.60%11.222.0%$105.54m
BBIOBridgeBio Pharma, Inc. 2.53%30.420.0%$27.07m
RDYDr. Reddy's Laboratories Ltd. -1.64%51.462.0%$10.21m
COCPCocrystal Pharma, Inc. 3.90%1.600.0%$9.11m
TXMDTherapeuticsMD, Inc. 4.80%1.5322.1%$8.79m
ABEOAbeona Therapeutics, Inc. 9.33%3.404.5%$3.30m
TAROTaro Pharmaceutical Industries Ltd. -1.80%66.976.5%$2.26m
CPHIChina Pharma Holdings, Inc. -0.67%0.580.1%$1.99m
KINKindred Biosciences, Inc. -4.21%3.870.3%$1.98m
JAGXJaguar Health, Inc. 10.20%0.541.7%$1.89m
LFVNLifeVantage Corp. 2.92%13.033.3%$1.29m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.